Astria Therapeutics, Inc.
Developing long-acting therapies for rare allergic and immunologic diseases like HAE.
ATXS | NDAQ
Overview
Corporate Details
- ISIN(s):
- US04635X1028
- LEI:
- Country:
- United States of America
- Address:
- 22 BOSTON WHARF ROAD, 2210 BOSTON
- Website:
- https://astriatx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Astria Therapeutics, Inc. is a biopharmaceutical company dedicated to developing life-changing therapies for patients with rare allergic and immunologic diseases. The company employs a patient-centric approach, guided by the experiences and needs of patient communities to inform its research and development efforts. Its clinical pipeline is focused on creating differentiated therapeutics, with a key program being STAR-0215, a potential long-acting preventative treatment for Hereditary Angioedema (HAE). Astria's mission is to combine science with compassion to bring hope and meaningful improvements to the lives of patients and their families.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Astria Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Astria Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Astria Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
